Take a look a the interview with Jane Foster, Associate Professor, Department of Psychiatry and Behavioural Neurosciences at McMaster University.
“The current attention to tool development for analysis beyond bacterial composition is one advance that will help scientists address the growing list of challenges”
“Dietary approaches such as probiotics and prebiotics are attractive to the public and have great therapeutic potential in mental health”
Download to find out why Rebiotix could have the first marketed microbiome-directed product by 2019
Download to read Dana Barberio, Msc, Edge Bioscience Communications’ Microbiome Drug Development Summit 2017 Post Event Report.
Download to find out what Dirk Gever’s view is on the single most important challenge that needs addressing to progress microbiome innovation into therapeutic success.
Dana Barberio, Edge BioScience Communications, has written a pre-conference report to give you more insight into the action ready to unfold at the Microbiome Drug Development Summit 2017